Download PDF
Facial Plast Surg 2017; 33(01): 087-096
DOI: 10.1055/s-0036-1597685
Rapid Communication
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hyaluronic Acid Fillers in Soft Tissue Regeneration

Arianna Fallacara
1   Department of Life Science and Biotechnology, Universita degli Studi di Ferrara Dipartimento di Scienze della Vita e Biotecnologie, Ferrara, Emilia-Romagna, Italy
,
Stefano Manfredini
1   Department of Life Science and Biotechnology, Universita degli Studi di Ferrara Dipartimento di Scienze della Vita e Biotecnologie, Ferrara, Emilia-Romagna, Italy
,
Elisa Durini
1   Department of Life Science and Biotechnology, Universita degli Studi di Ferrara Dipartimento di Scienze della Vita e Biotecnologie, Ferrara, Emilia-Romagna, Italy
,
Silvia Vertuani
1   Department of Life Science and Biotechnology, Universita degli Studi di Ferrara Dipartimento di Scienze della Vita e Biotecnologie, Ferrara, Emilia-Romagna, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
22 February 2017 (online)

    Permissions and Reprints

Corrected by:

Erratum: Hyaluronic Acid Fillers in Soft Tissue RegenerationFacial Plast Surg 2017; 33(02): 244-244
DOI: 10.1055/s-0037-1601851

Abstract

Over the last years, hyaluronic acid (HA) injectable dermal fillers (DFs) have become the most popular agents for soft tissue contouring and volumizing. HA fillers are characterized by most of the properties that an ideal DF should have, due to HA unique chemical-physical properties, biocompatibility, biodegradability, and versatility. Therefore, HA DFs have revolutionized the filler market with a high number of products, which differ in terms of HA source, cross-linkage (agent and degree), HA concentration, hardness, cohesivity, consistency, inclusion or lack of anesthetic, indication, and longevity of correction. The article first provides a general introduction to DF world, and an overview of the different materials is available for fillers. Second, it describes the characteristics and the peculiarities of HA fillers, their differences from the other available materials, and therefore the reasons at the base of their success. Moreover, an update regarding the main Food and Drug Administration (FDA) approved fillers is presented.

Keywords

dermal filler - hyaluronic acid - soft tissue voluminization - aesthetic medicine - nonsurgical procedures
 

  • References

  • 1 American Society of Plastic Surgeons (ASPS) 2015 Complete plastic surgery statistics report. http://www.plasticsurgery.org/news/plastic-surgery-statistics/2015-plastic-surgery-statistics.html . Accessed August 8, 2016
    PubMedGoogle Scholar
  • 2 Bogdan Allemann I, Baumann L. Hyaluronic acid gel (Juvéderm) preparations in the treatment of facial wrinkles and folds. Clin Interv Aging 2008; 3 (4) 629-634
    CrossrefPubMedGoogle Scholar
  • 3 Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol 2013; 6 (1) 295-316
    Google Scholar
  • 4 Muhn C, Rosen N, Solish N , et al. The evolving role of hyaluronic acid fillers for facial volume restoration and contouring: a Canadian overview. Clin Cosmet Investig Dermatol 2012; 5: 147-158
    PubMedGoogle Scholar
  • 5 Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol 2006; 17 (5) 471-479
    CrossrefPubMedGoogle Scholar
  • 6 Hotta T. Dermal fillers. The next generation. Plast Surg Nurs 2004; 24 (1) 14-19
    CrossrefPubMedGoogle Scholar
  • 7 Carruthers J, Rzany B, Sattler G, Carruthers A. Anatomic guidelines for augmentation of the cheek and infraorbital hollow. Dermatol Surg 2012; 38 (7 Pt 2): 1223-1233
    CrossrefPubMedGoogle Scholar
  • 8 Pierre S, Liew S, Bernardin A. Basics of dermal filler rheology. Dermatol Surg 2015; 41 (1) (Suppl. 01) S120-S126
    CrossrefPubMedGoogle Scholar
  • 9 Couarraze G, Grossiord JL. Initiation à la rheologie. 3rd ed. Paris, France: TEC & DOC; 2000: 300
    Google Scholar
  • 10 Santoro S, Russo L, Argenzio V, Borzacchiello A. Rheological properties of cross-linked hyaluronic acid dermal fillers. J Appl Biomater Biomech 2011; 9 (2) 127-136
    PubMedGoogle Scholar
  • 11 Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg 2010; 36 (3) (Suppl. 03) 1859-1865
    CrossrefPubMedGoogle Scholar
  • 12 Jones DH. Semipermanent and permanent injectable fillers. Dermatol Clin 2009; 27 (4) 433-444 , vi
    CrossrefPubMedGoogle Scholar
  • 13 Kulichova D, Borovaya A, Ruzicka T, Thomas P, Gauglitz GG. Understanding the safety and tolerability of facial filling therapeutics. Expert Opin Drug Saf 2014; 13 (9) 1215-1226
    CrossrefPubMedGoogle Scholar
  • 14 Sapijaszko MJA. Dermal fillers: ever-expanding options for esthetic use. Skin Therapy Lett 2007; 12 (8) 4-7
    PubMedGoogle Scholar
  • 15 Food and Drug Administration. Soft Tissue Fillers (Dermal Fillers). http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/CosmeticDevices/WrinkleFillers/default.htm#Materials . Accessed August 8, 2016
    PubMedGoogle Scholar
  • 16 Duffy DM. Liquid silicone for soft tissue augmentation. Dermatol Surg 2005; 31 (11 Pt 2): 1530-1541
    CrossrefPubMedGoogle Scholar
  • 17 Kontis TC. Contemporary review of injectable facial fillers. JAMA Facial Plast Surg 2013; 15 (1) 58-64
    CrossrefPubMedGoogle Scholar
  • 18 Kontis TC, Rivkin A. The history of injectable facial fillers. Facial Plast Surg 2009; 25 (2) 67-72
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin 2005; 23 (2) 343-363
    CrossrefPubMedGoogle Scholar
  • 20 Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging 2008; 3 (1) 161-174
    CrossrefPubMedGoogle Scholar
  • 21 Baumann L. Replacing dermal constituents lost through aging with dermal fillers. Semin Cutan Med Surg 2004; 23 (3) 160-166
    CrossrefPubMedGoogle Scholar
  • 22 Laurent TC, Laurent UBG, Fraser JRE. Functions of hyaluronan. Ann Rheum Dis 1995; 54 (5) 429-432
    CrossrefPubMedGoogle Scholar
  • 23 Liao YH, Jones SA, Forbes B, Martin GP, Brown MB. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 2005; 12 (6) 327-342
    CrossrefPubMedGoogle Scholar
  • 24 Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, La Rotonda MI. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm 2008; 70 (1) 199-206
    CrossrefPubMedGoogle Scholar
  • 25 Scott JE, Heatley F. Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study. Proc Natl Acad Sci U S A 1999; 96 (9) 4850-4855
    CrossrefPubMedGoogle Scholar
  • 26 Scott JE, Secondary structures in hyaluronan solutions: chemical and biological implications. In: Evered D, Whelan J. , eds. Ciba Foundation Symposium 143—The Biology of Hyaluronian. Chichester, UK: Whiley; 1989: 6-20
    PubMedGoogle Scholar
  • 27 Lapcík Jr L, Lapcík L, De Smedt S, Demeester J, Chabrecek P. Hyaluronan: preparation, structure, properties, and applications. Chem Rev 1998; 98 (8) 2663-2684
    CrossrefPubMedGoogle Scholar
  • 28 Ramamurthi A, Vesely I. Smooth muscle cell adhesion on crosslinked hyaluronan gels. J Biomed Mater Res 2002; 60 (1) 195-205
    CrossrefPubMedGoogle Scholar
  • 29 Tomihata K, Ikada Y. Preparation of cross-linked hyaluronic acid films of low water content. Biomaterials 1997; 18 (3) 189-195
    CrossrefPubMedGoogle Scholar
  • 30 Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 2008; 10 (1) 35-42
    Google Scholar
  • 31 Borrell M, Leslie DB, Tezel A. Lift capabilities of hyaluronic acid fillers. J Cosmet Laser Ther 2011; 13 (1) 21-27
    CrossrefPubMedGoogle Scholar
  • 32 Ho D, Jagdeo J. Biological properties of a new volumizing hyaluronic acid filler: a systematic review. J Drugs Dermatol 2015; 14 (1) 50-54
    PubMedGoogle Scholar
  • 33 Cavallini M, Gazzola R, Metalla M, Vaienti L. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthet Surg J 2013; 33 (8) 1167-1174
    CrossrefPubMedGoogle Scholar
  • 34 Tajana G, Bianchi L, Iorio V, Lisi P. Efficacia e sicurezza dell'acido ialuronico in dermocosmesi: il “caso” Viscoderm®. Ann Ital Dermatol Allergol 2011; 65: 106-112
    PubMedGoogle Scholar
  • 35 Price RD, Berry MG, Navsaria HA. Hyaluronic acid: the scientific and clinical evidence. J Plast Reconstr Aesthet Surg 2007; 60 (10) 1110-1119
    CrossrefPubMedGoogle Scholar
  • 36 Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol 2008; 7 (4) 251-258
    CrossrefPubMedGoogle Scholar
  • 37 Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging 2007; 2 (3) 369-376
    CrossrefPubMedGoogle Scholar
  • 38 Medical Insight, Inc.,; 2006 Global market for dermal fillers. 2005-2011
    PubMedGoogle Scholar
  • 39 Ballin AC, Cazzaniga A, Brandt FS. Long-term efficacy, safety and durability of Juvéderm® XC. Clin Cosmet Investig Dermatol 2013; 6: 183-189
    PubMedGoogle Scholar
  • 40 Carruthers J, Carruthers A, Tezel A, Kraemer J, Craik L. Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy. Dermatol Surg 2010; 36 (3) (Suppl. 03) 1886-1892
    CrossrefPubMedGoogle Scholar
  • 41 Goodman GJ. An interesting reaction to a high- and low-molecular weight combination hyaluronic acid. Dermatol Surg 2015; 41 (1) (Suppl. 01) S164-S166
    CrossrefPubMedGoogle Scholar
  • 42 Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 2008; 3 (1) 153-159
    CrossrefPubMedGoogle Scholar
  • 43 Micheels P, Sarazin D, Besse S, Sundaram H, Flynn TC. A blanching technique for intradermal injection of the hyaluronic acid Belotero. Plast Reconstr Surg 2013; 132 (4) (Suppl. 02) 59S-68S
    CrossrefPubMedGoogle Scholar
  • 44 Tran C, Carraux P, Micheels P, Kaya G, Salomon D. In vivo bio-integration of three hyaluronic acid fillers in human skin: a histological study. Dermatology 2014; 228 (1) 47-54
    CrossrefPubMedGoogle Scholar
  • 45 Kablik J, Monheit GD, Yu L, Chang G, Gershkovich J. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg 2009; 35 (Suppl. 01) 302-312
    CrossrefPubMedGoogle Scholar
  • 46 Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003; 29 (8) 802-809
    CrossrefPubMedGoogle Scholar
  • 47 Môle B. Scratched faces: treatment of dynamic facial wrinkles through the simultaneous combined use of botulinium toxin A and hyaluronic acid [in French]. Ann Chir Plast Esthet 2012; 57 (3) 194-201
    CrossrefPubMedGoogle Scholar
  • 48 Kenner JR. Hyaluronic acid filler and botulinum neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy. J Drugs Dermatol 2010; 9 (9) 1135-1138
    PubMedGoogle Scholar
  • 49 Kenner J. Combining fillers and neuromodulators in the same syringe. J Drugs Dermatol 2014; 13 (2) 110
    PubMedGoogle Scholar
  • 50 Cohen JL, Mariwall K. Combining fillers and neuromodulators in the same syringe. J Drugs Dermatol 2013; 12 (9) 976
    PubMedGoogle Scholar
  • 51 Citernesi UR, Beretta L, Citernesi L. Cross-linked hyaluronic acid, process for the preparation thereof and use thereof. Patent WO/2015/007773 A1; 2015
    PubMedGoogle Scholar
  • 52 Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatol Online J 2013; 19 (11) 20392
    PubMedGoogle Scholar
  • 53 Charlton JF, Schwab IR, Stuchell R. Topical urea as a treatment for non-infectious keratopathy. Acta Ophthalmol Scand 1996; 74 (4) 391-394
    PubMedGoogle Scholar
  • 54 Fallacara A, Vertuani S, Disette V, Panozzo G, Manfredini S. Novel cross-linked hyaluronic acid: an in vitro re-epithelialization study. 2016 , manuscript submitted
    PubMedGoogle Scholar